BC
SRPT icon

Brinker Capital’s Sarepta Therapeutics SRPT Stock Holding History

Brinker Capital’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$669K Sell
4,173
-345
-8% -$46.9K 0.02% 626
2020
Q1 		$442K Sell
4,518
-29
-0.6% -$3.31K 0.02% 677
2019
Q4 		$587K Buy
4,547
+1,683
+59% +$170K 0.02% 670
2019
Q3 		$216K Buy
2,864
+197
+7% +$23.3K 0.01% 901
2019
Q2 		$405K Buy
2,667
+370
+16% +$45K 0.01% 731
2019
Q1 		$274K Buy
+2,297
New +$295K 0.01% 820
2018
Q3 		– Sell
-2,277
Closed -$301K – 1013
2018
Q2 		$301K Buy
+2,277
New +$215K 0.01% 862
2018
Q1 		– Sell
-4,034
Closed -$224K – 1023
2017
Q4 		$224K Buy
+4,034
New +$214K 0.01% 926

Other funds holding SRPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return